Skip to main content

Table 1 MYC , FBXW7 and TP53 gene copy number variation, MYC and p53 protein expression and clinicopathological features of 33 GC patients

From: MYC, FBXW7 and TP53 copy number variation and expression in Gastric Cancer

 

CNV MYC

CNV FBXW7

 

CNV TP53

 

IHC MYC

IHC p53

 

2 copies (n = 16)

≥ 3 copies (n = 17)

p- value

2 copies (n = 18)

1 copy (n = 15)

p- value

2 copies (n = 25)

1 copy (n = 7)

p- value

P (n = 19)

N (n = 14)

p- value

P (n = 6)

N (n = 25)

p- value

Age (y) (mean ± SD)

>50 (65.3 ± 9.1)

7

12

0.166

12

7

0.304

15

3

0.393

10

4

0.310

5

9

0.094

≤50 (42.1 ± 8.2)

9

5

 

6

8

 

10

4

 

10

9

 

2

17

 

Gender

Male

8

7

0.437

7

8

1.000

13

1

0.104

12

3

0.072

2

13

0.413

Female

8

10

 

8

10

 

12

6

 

8

10

 

5

13

 

Histopathology

Intestinal

12

10

0.465

12

10

1.000

16

6

0.387

17

5

0.009*

6

16

0.378

Diffuse

4

7

 

6

5

 

9

1

 

3

8

 

1

10

 

Depth of tumor invasion

T1

3

3

1.000

5

1

0.186

5

1

1.000

2

4

0.182

1

5

1.000

T2-T4

13

14

 

13

14

 

20

6

 

18

9

 

6

21

 

Lymph node metastasis

Absent

5

8

0.481

8

5

0.722

10

3

1.000

7

6

0.717

2

11

0.676

Present

11

9

 

10

10

 

15

4

 

13

7

 

5

15

 

Stage

I-II

8

10

0.732

12

6

0.170

14

3

0.678

12

6

0.493

3

15

0.674

III-IV

8

7

 

6

9

 

11

4

 

8

7

 

4

11

 

MYC IHC

Negative

5

8

0.481

7

6

1.000

11

2

0.671

      

Positive

11

9

 

11

9

 

14

5

       

p53 IHC

Negative

14

12

0.398

14

12

1.000

21

4

0.157

      

Positive

2

5

 

4

3

 

4

3

       
  1. *p < 0.05; P: positive; N: negative.